Ferguson Merle 4

4 · BIOFORCE NANOSCIENCES HOLDINGS, INC. · Filed Oct 18, 2023

Insider Transaction Report

Form 4
Period: 2023-10-17
Ferguson Merle
DirectorCEO/President/Treasurer10% Owner
Transactions
  • Gift

    Common Stock

    2023-10-17+1,470,00016,470,000 total
  • Gift

    Common Stock

    2023-10-171,470,00015,000,000 total(indirect: Shares Held in Private Company)
  • Gift

    Common Stock

    2023-10-18+1,400,00017,870,000 total
Footnotes (1)
  • [F1]15,000,000 share are held directly by the reporting individual, 1,470,000 shares held indirectly in a business entity that the reporting person is an executive officer was gifted to the reporting person. The private company controlled by the reporting individual has -0- shares, no longer has shares of the issuer.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT